Disclaimer

Safe Harbor Statement Under the Private Securities Litigation Reform Act, as amended:
With the exception of the historical statements, statements contained in this Website may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are generally identifiable by the use of the words "believes," "views," "expects," "projects," "hopes," "could," "will," "intends," "should," "estimate," "would," "may," "anticipates," "plans", "target", "goal" or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are subject to a number of risks and uncertainties that may, individually or collectively, cause actual results to differ materially from those contained in the forward-looking information, and are based on the current expectations, estimates, forecasts and projections of Perosphere Pharmaceuticals Inc. ("Perosphere Pharmaceuticals"). Many of the risks and uncertainties are outside the control of Perosphere Pharmaceuticals. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in Perosphere Pharmaceuticals' offering documents and its other filings with the SEC. Forward-looking statements contained in this Website speak only as of the date thereof. Except as required by law, Perosphere Pharmaceuticals undertakes no obligation to publicly release the results of any revisions or updates to these forward-looking statements that may be made to reflect events or circumstances after the date thereof, or to reflect the occurrence of unanticipated events. Perosphere Pharmaceuticals disclaims any intention to update this Website to reflect actual subsequent events.